Literature DB >> 22623532

Exposure therapy triggers lasting reorganization of neural fear processing.

Katherina K Hauner1, Susan Mineka, Joel L Voss, Ken A Paller.   

Abstract

A single session of exposure therapy can eliminate recalcitrant and disabling fear of phobogenic objects or situations. We studied neural mechanisms of this remarkable outcome by monitoring changes in brain activity as a result of successful 2-h treatment. Before treatment, phobogenic images excited activity in a network of regions, including amygdala, insula, and cingulate cortex, relative to neutral images. Successful therapy dampened responsiveness in this fear-sensitive network while concomitantly heightening prefrontal involvement. Six months later, dampened fear-network activity persisted but without prefrontal engagement. Additionally, individual differences in the magnitude of visual cortex activations recorded shortly after therapy predicted therapeutic outcomes 6 mo later, which involved persistently diminished visual responsiveness to phobogenic images. Successful therapy thus entailed stable reorganization of neural responses to initially feared stimuli. These effects were linked to fear-extinction mechanisms identified in animal models, thus opening new opportunities for the treatment and prevention of debilitating anxiety disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22623532      PMCID: PMC3384187          DOI: 10.1073/pnas.1205242109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  One vs five sessions of exposure and five sessions of cognitive therapy in the treatment of claustrophobia.

Authors:  L G Ost; T Alm; M Brandberg; E Breitholtz
Journal:  Behav Res Ther       Date:  2001-02

Review 2.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

Review 3.  The emotional brain, fear, and the amygdala.

Authors:  Joseph LeDoux
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 4.  The neurobiology of consolidations, or, how stable is the engram?

Authors:  Yadin Dudai
Journal:  Annu Rev Psychol       Date:  2004       Impact factor: 24.137

5.  Rethinking feelings: an FMRI study of the cognitive regulation of emotion.

Authors:  Kevin N Ochsner; Silvia A Bunge; James J Gross; John D E Gabrieli
Journal:  J Cogn Neurosci       Date:  2002-11-15       Impact factor: 3.225

6.  Extinction learning in humans: role of the amygdala and vmPFC.

Authors:  Elizabeth A Phelps; Mauricio R Delgado; Katherine I Nearing; Joseph E LeDoux
Journal:  Neuron       Date:  2004-09-16       Impact factor: 17.173

7.  Learning-induced changes in mPFC-BLA connections after fear conditioning, extinction, and reinstatement of fear.

Authors:  Rose-Marie Vouimba; Mouna Maroun
Journal:  Neuropsychopharmacology       Date:  2011-07-13       Impact factor: 7.853

8.  "Change the mind and you change the brain": effects of cognitive-behavioral therapy on the neural correlates of spider phobia.

Authors:  Vincent Paquette; Johanne Lévesque; Boualem Mensour; Jean-Maxime Leroux; Gilles Beaudoin; Pierre Bourgouin; Mario Beauregard
Journal:  Neuroimage       Date:  2003-02       Impact factor: 6.556

9.  Encoding activity in the medial temporal lobe examined with anatomically constrained fMRI analysis.

Authors:  Paul J Reber; Eric C Wong; Richard B Buxton
Journal:  Hippocampus       Date:  2002       Impact factor: 3.899

10.  Human orbitofrontal cortex mediates extinction learning while accessing conditioned representations of value.

Authors:  Jay A Gottfried; Raymond J Dolan
Journal:  Nat Neurosci       Date:  2004-09-12       Impact factor: 24.884

View more
  37 in total

Review 1.  Neuroimaging of Fear-Associated Learning.

Authors:  John A Greco; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2015-08-21       Impact factor: 7.853

2.  Sleeping in a Brave New World: Opportunities for Improving Learning and Clinical Outcomes through Targeted Memory Reactivation.

Authors:  Ken A Paller
Journal:  Curr Dir Psychol Sci       Date:  2017-11-01

Review 3.  Changing views of emotion regulation and neurobiological models of the mechanism of action of psychotherapy.

Authors:  Irene Messina; Marco Sambin; Petra Beschoner; Roberto Viviani
Journal:  Cogn Affect Behav Neurosci       Date:  2016-08       Impact factor: 3.282

4.  Psychotherapy and Neuroimaging.

Authors:  Jay C Fournier; Rebecca B Price
Journal:  Focus (Am Psychiatr Publ)       Date:  2014-07-01

5.  Neural changes with attention bias modification for anxiety: a randomized trial.

Authors:  Jennifer C Britton; Jenna G Suway; Michelle A Clementi; Nathan A Fox; Daniel S Pine; Yair Bar-Haim
Journal:  Soc Cogn Affect Neurosci       Date:  2014-10-24       Impact factor: 3.436

Review 6.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17

7.  Cortical Thickness and Subcortical Gray Matter Volume in Pediatric Anxiety Disorders.

Authors:  Andrea L Gold; Elizabeth R Steuber; Lauren K White; Jennifer Pacheco; Jessica F Sachs; David Pagliaccio; Erin Berman; Ellen Leibenluft; Daniel S Pine
Journal:  Neuropsychopharmacology       Date:  2017-04-24       Impact factor: 7.853

8.  Unconscious Psychological Treatments for Physiological Survival Circuits.

Authors:  Vincent Taschereau-Dumouchel; Ka-Yuet Liu; Hakwan Lau
Journal:  Curr Opin Behav Sci       Date:  2018-05-04

9.  Passive avoidance is linked to impaired fear extinction in humans.

Authors:  Brian R Cornwell; Cassie Overstreet; Marissa Krimsky; Christian Grillon
Journal:  Learn Mem       Date:  2013-02-20       Impact factor: 2.460

10.  Behavioral and neural stability of attention bias to threat in healthy adolescents.

Authors:  Lauren K White; Jennifer C Britton; Stefanie Sequeira; Emily G Ronkin; Gang Chen; Yair Bar-Haim; Tomer Shechner; Monique Ernst; Nathan A Fox; Ellen Leibenluft; Daniel S Pine
Journal:  Neuroimage       Date:  2016-04-27       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.